Laser

logo et courbe des catégory quantel medical


Cataract and glaucoma laser platform

Optimis Fusion is a versatile laser platform combining YAG photodisruption treatments and advanced SLT photoregeneration therapy in one fully integrated system.

Upgradable, it can easily be transformed into an anterior and posterior laser treatment platform by combing it with a compatible Quantel Medical retina laser.

Key features:

  • Premium optics for viewing both the anterior and posterior segments.
  • Quantel Medical proprietary technology: dual-mode YAG/SLT laser cavity. 

Premium Optics

Built into a premium Zeiss type slit lamp Optimis Fusion provides a superior vision of both the anterior and posterior chambers.

It features a LED illumination source providing a sharp, bright and homogeneous illumination.

Advanced technology

Dual-mode YAG / SLT laser cavity, optimized to produce 1064nm and 532nm nanosecond pulses from one laser cavity.

Powerful, precise and efficient Nd:YAG Laser / Full-featured SLT laser

Easy switch from YAG to SLT mode, easy to use software

Advanced combination laser platform

Fully integrated glaucoma and cataract laser platform

Optimis Fusion easily combines with Quantel Medical Vitra 2 monospot or multispot photocoagulators, offering a YAG , SLT and Multispot Retina Laser platform all in one. More information

Precise & Powerful

Optimis Fusion YAG laser delivers high-performance photodisruption for capsulotomy and peripheral iridotomy. Its gaussian laser beam profile allows for precise delivery, only requiring minimum energy levels, which avoids side effects such as lens pitting.

Precise tissue targeting is achieved with the advanced two-point aiming beam, allowing for fast and accurate targeting of the capsule; and the adjustable offset feature, allowing for easy focus adjustment behind or at the point of disruption.

5d654c97e3cb4_Precise-and-powerful.png

SLT laser therapy

5d6627b4a5f1b_SLT-Laser-therapy.png

First line treatment. No thermal Damage. Repeatable.
Selective Laser Trabeculoplasty (SLT) is a proven therapy supported by more than 10 years of clinical data. SLT targets melanin-rich cells which absorb the laser energy to induce a healing response that begins to restore the function of the trabecular meshwork.

The laser energy is delivered in short, fixed pulses over a large, homogeneous spot size, resulting in no thermal damage. Due to the gentle delivery and no permanent destruction to the trabecular meshwork, SLT leaves the structures intact and can be repeated if necessary.

Symposium

Interview

Vitra 2

Vitra 2

Retinal Photocoagulation

Multispot Laser Adaptator

Multispot Laser Adaptator

Vitra 2 Laser adapator